Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SBR004
MIFTS: 42

Seborrheic Dermatitis

Categories: Skin diseases
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Seborrheic Dermatitis

About this section

MalaCards integrated aliases for Seborrheic Dermatitis:

Name: Seborrheic Dermatitis 12 37 29 55 15 73
Seborrhoeic Dermatitis 12
Dermatitis, Seborrheic 44
Seborrhoeic Eczema 12
Skin Seborrheic 12
Seborrhea 12

Classifications:

MalaCards categories:
Anatomical: Skin diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:8741
ICD10 33 L21 L21.9
ICD9CM 35 690.1 690.10 706.3
MeSH 44 D012628
NCIt 50 C111888
SNOMED-CT 68 50563003 86708008
KEGG 37 H01652
UMLS 73 C0036508
Sources

Summaries for Seborrheic Dermatitis

About this section
Disease Ontology : 12 A dermatitis that is an inflammatory skin condition resulting in flaky, white to yellowish scales on oily areas such as the scalp or inside the ear, which is caused due to a combination of an over production of skin oil and irritation from a yeast Malassezia furfur. The symptoms include itching, skin lesions and scales, redness, plaques and hair loss.

MalaCards based summary : Seborrheic Dermatitis, also known as seborrhoeic dermatitis, is related to seborrhea-like dermatitis with psoriasiform elements and seborrheic infantile dermatitis. An important gene associated with Seborrheic Dermatitis is BTD (Biotinidase). The drugs Salicylic acid and Isotretinoin have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and eye, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Seborrhoeic dermatitis, also known as seborrhoea, is a long-term skin disorder. Symptoms include red,... more...

Sources

Related Diseases for Seborrheic Dermatitis

About this section

Diseases in the Seborrheic Dermatitis family:

Seborrheic Infantile Dermatitis

Diseases related to Seborrheic Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 79)
# Related Disease Score Top Affiliating Genes
1 seborrhea-like dermatitis with psoriasiform elements 12.6
2 seborrheic infantile dermatitis 12.2
3 garret tripp syndrome 11.3
4 dermatitis 11.2
5 leiner disease 11.1
6 keratosis, seborrheic 11.1
7 psoriasis 10.6
8 dermatitis, atopic 10.3
9 complement component 5 deficiency 10.3
10 pityriasis versicolor 10.3
11 neurofibromatosis, type ii 10.3
12 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.3
13 human immunodeficiency virus infectious disease 10.2
14 acquired immunodeficiency syndrome 10.2
15 rosacea 10.2
16 tinea capitis 10.2
17 alopecia 10.1
18 herpes zoster 10.1
19 contact dermatitis 10.1
20 lupus erythematosus 10.1
21 androgenic alopecia 10.1 LPP SHBG
22 myiasis 10.0
23 pseudovaginal perineoscrotal hypospadias 10.0 AHR CGA
24 complete androgen insensitivity syndrome 10.0 CGA SHBG
25 androgen insensitivity syndrome 10.0 CGA SHBG
26 gynecomastia 10.0 CGA SHBG
27 legg-calve-perthes disease 10.0
28 systemic lupus erythematosus 10.0
29 benign chronic pemphigus 10.0
30 lung cancer 10.0
31 polydactyly 10.0
32 basal cell carcinoma 1 10.0
33 crohn's disease 10.0
34 granuloma annulare 10.0
35 urticaria 10.0
36 basal cell carcinoma 10.0
37 superficial basal cell carcinoma 10.0
38 mite infestation 10.0
39 depression 10.0
40 anovulation 10.0 CGA SHBG
41 varicocele 10.0 CGA SHBG
42 testicular cancer 9.9 CGA SHBG
43 renal cell carcinoma, nonpapillary 9.9
44 keratopathy 9.9
45 leukemia 9.9
46 skin conditions 9.9
47 skin disease 9.9
48 erythema multiforme 9.9
49 biotin deficiency 9.9
50 lymphoma 9.9

Graphical network of the top 20 diseases related to Seborrheic Dermatitis:



Diseases related to Seborrheic Dermatitis
Sources

Symptoms & Phenotypes for Seborrheic Dermatitis

About this section

GenomeRNAi Phenotypes related to Seborrheic Dermatitis according to GeneCards Suite gene sharing:

26 (show all 11)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-16 9.4 IDH2
2 Increased shRNA abundance (Z-score > 2) GR00366-A-169 9.4 SHBG
3 Increased shRNA abundance (Z-score > 2) GR00366-A-176 9.4 IDH2
4 Increased shRNA abundance (Z-score > 2) GR00366-A-177 9.4 IDH2
5 Increased shRNA abundance (Z-score > 2) GR00366-A-199 9.4 IDH2
6 Increased shRNA abundance (Z-score > 2) GR00366-A-207 9.4 SHBG
7 Increased shRNA abundance (Z-score > 2) GR00366-A-42 9.4 IDH2
8 Increased shRNA abundance (Z-score > 2) GR00366-A-45 9.4 SHBG
9 Increased shRNA abundance (Z-score > 2) GR00366-A-46 9.4 SHBG
10 Increased shRNA abundance (Z-score > 2) GR00366-A-69 9.4 IDH2 SHBG
11 Increased shRNA abundance (Z-score > 2) GR00366-A-73 9.4 IDH2
Sources

Drugs & Therapeutics for Seborrheic Dermatitis

About this section

Drugs for Seborrheic Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 122)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Salicylic acid Approved, Investigational, Vet_approved Phase 4 69-72-7 338
2
Isotretinoin Approved Phase 4 4759-48-2 5538 5282379
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 22916-47-8 4189
4
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
5
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
6
Polyestradiol phosphate Approved Phase 4 28014-46-2
7
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
8 Estradiol valerate Approved, Investigational, Vet_approved Phase 4 979-32-8
9
Tacrolimus Approved, Investigational Phase 4,Phase 3 104987-11-3 445643 439492
10
Ketoconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 65277-42-1 3823 47576
11
Drospirenone Approved Phase 4 67392-87-4 68873
12
Desogestrel Approved Phase 4 54024-22-5 40973
13
Benzoyl peroxide Approved Phase 4,Phase 1,Phase 2 94-36-0 7187
14
Norgestrel Approved Phase 4 6533-00-2 13109
15
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
16
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
17
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
18 Salicylates Phase 4
19 Keratolytic Agents Phase 4
20 Analgesics Phase 4,Phase 2,Phase 1
21 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 1
22 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
24 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Not Applicable
25 Antirheumatic Agents Phase 4,Phase 2,Phase 1
26 Dermatologic Agents Phase 4,Phase 2,Phase 1,Not Applicable
27 Cyclooxygenase Inhibitors Phase 4
28 Antifungal Agents Phase 4,Phase 3,Phase 2,Not Applicable
29 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 1
30 Emollients Phase 4,Not Applicable
31 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
32 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
33 Hormones Phase 4,Phase 3,Phase 2,Not Applicable
34 Contraceptive Agents Phase 4,Phase 1,Phase 2
35 Estrogens Phase 4
36 Estradiol 17 beta-cypionate Phase 4
37 Estradiol 3-benzoate Phase 4
38 Calcineurin Inhibitors Phase 4,Phase 3,Phase 2
39 Immunologic Factors Phase 4,Phase 3,Phase 2,Not Applicable
40 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Not Applicable
41 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
42 Steroid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
43 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
44 Diuretics, Potassium Sparing Phase 4
45 Trace Elements Phase 4
46 Vitamin B9 Phase 4
47 Vitamins Phase 4
48 Drospirenone and ethinyl estradiol combination Phase 4
49 Insulin, Globin Zinc Phase 4
50 Natriuretic Agents Phase 4

Interventional clinical trials:

(show all 39)
# Name Status NCT ID Phase Drugs
1 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
2 Promiseb Topical Cream for Cradle Cap Completed NCT01214434 Phase 4
3 Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis Completed NCT01591070 Phase 4 Tacrolimus;Tacrolimus
4 STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% Completed NCT00703846 Phase 4 Ketoconazole
5 Safety and Efficacy of Ketoconazole 2% Foam in the Treatment of Pityrosporum Folliculitis Completed NCT00824863 Phase 4 ketoconazole 2% foam
6 Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance Completed NCT01511822 Phase 4 Drospirenone Ethinyl estradiol;Drospirenone Ethinyl estradiol Myo-inositol;placebo
7 An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment Completed NCT01466673 Phase 4 Ethinyl estradiol/Norgestimate (EE/NGM);Ethinyl estradiol/Desogestrel (EE/DSG)
8 A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis Recruiting NCT03567980 Phase 4 Crisaborole
9 Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis Unknown status NCT01011621 Phase 3 0.5% prednisolone acetate cream;0.1% betamethasone valerate cream
10 Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis Completed NCT02004860 Phase 3 Protopic (R);Mycoster (R)
11 Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis Completed NCT00862654 Phase 3 clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week) - ketoconazole shampoo (2/week);clobetasol propionate shampoo (2/week);ketoconazole shampoo (2/week)
12 Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis Completed NCT00565279 Phase 3 ASF1057;ASF1057
13 Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp Completed NCT01137630 Phase 2, Phase 3 K40a;K40b;Placebo
14 K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp Completed NCT01137331 Phase 3 K301;Placebo
15 A 4 Week Study of Elidel for the Treatment of Seborrheic Dermatitis Completed NCT00403559 Phase 2 Elidel
16 A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face Completed NCT00408330 Phase 2 Azelaic Acid 15% Gel;Inactive 15% gel base
17 A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis Completed NCT02749383 Phase 2 PAC-14028 cream 0.3%;PAC-14028 cream 1.0%;PAC-14028 cream vehicle
18 Safety and Efficacy Study in Subjects With Seborrheic Dermatitis Completed NCT01703793 Phase 2 Test Product 49778;Test Product 10156;Vehicle (placebo)
19 Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers Completed NCT01254162 Phase 2 MTC896 Gel
20 The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage Completed NCT00991198 Phase 2 Topical oxygen;Topical oxygen;placebo
21 Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis Recruiting NCT03688971 Phase 2 Omiganan;Ketoconazole;Placebo
22 Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne Recruiting NCT03076320 Phase 1, Phase 2
23 A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease Recruiting NCT03582137 Phase 2 Cannabidiol
24 Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients Unknown status NCT00767546 Phase 1 Botulinum toxin
25 Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation Unknown status NCT01315951 Not Applicable
26 Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face Unknown status NCT01024374
27 HIV Indicator Diseases Across Europe Study Unknown status NCT01681706
28 Drug Utilization Study on the Prescribing Indications for Cyproterone Acetate and Ethinyl Estradiol in 5 European Countries Unknown status NCT02494297
29 HIV Indicator Diseases Survey Across Europe - UK Arm Unknown status NCT01196468
30 Neurobiology of the Scalp in Seborrheic Dermatitis Completed NCT02349854
31 HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis Completed NCT00830908 Not Applicable
32 Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis Completed NCT02656368 Not Applicable
33 Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo Completed NCT01203189 Not Applicable ketoconazole 2% foam;ketoconazole 2% shampoo
34 An Investigator-Initiated Study to Assess the Cooling Effect of Triamcinolone Acetonide Aerosol When Used for Steroid-Responsive Dermatoses Completed NCT01736670 Not Applicable Triamcinolone Acetonide spray;Triamcinolone acetonide cream;Alcohol spray
35 Furocyst - Poly Cystic Ovary Syndrome Study Completed NCT02703064 Not Applicable
36 Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases Completed NCT02349399 Cyproterone / Ethinylestradiol (Diane-35, BAY86-5264) and its Generics
37 Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis Active, not recruiting NCT03114111 Not Applicable aminolevulinic acid (ALA);Placebo
38 Comparison of Scalp Microbiome of the Psoriasis and Seborrheic Dermatitis Patients Not yet recruiting NCT03807453
39 Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. Not yet recruiting NCT03186222

Search NIH Clinical Center for Seborrheic Dermatitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: dermatitis, seborrheic

Sources

Genetic Tests for Seborrheic Dermatitis

About this section

Genetic tests related to Seborrheic Dermatitis:

# Genetic test Affiliating Genes
1 Seborrheic Dermatitis 29
Sources

Anatomical Context for Seborrheic Dermatitis

About this section

MalaCards organs/tissues related to Seborrheic Dermatitis:

41
Skin, Testes, Eye, T Cells, Colon, Tongue, Lung
Sources

Publications for Seborrheic Dermatitis

About this section

Articles related to Seborrheic Dermatitis:

(show top 50) (show all 597)
# Title Authors Year
1
Chronic Nasolabial Fold Seborrheic Dermatitis Successfully Controlled With Crisaborole. ( 29742192 )
2018
2
Treatment of seborrheic dermatitis: a comprehensive review. ( 29737895 )
2018
3
<i>Staphylococcus aureus</i> is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis. ( 29785324 )
2018
4
Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion. ( 29410727 )
2018
5
Increased IL-17-expressing γδ T cells in seborrhoeic dermatitis-like lesions of the Mpzl3 knockout mice. ( 30307058 )
2018
6
Improvement of severe facial seborrheic dermatitis following low-dose isotretinoin therapy. ( 30249087 )
2018
7
Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil. ( 30051297 )
2018
8
Progressive Facial Papules in an African-American Patient: An Atypical Presentation of Seborrheic Dermatitis. ( 30057666 )
2018
9
Association between Diet and Seborrheic Dermatitis: A Cross-Sectional Study. ( 30130619 )
2018
10
Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. ( 28589618 )
2018
11
The genetic basis of seborrhoeic dermatitis: a review. ( 29152796 )
2018
12
Topical Medications for Seborrheic Dermatitis. ( 28290646 )
2017
13
Dasatinib-induced Seborrheic Dermatitis-like Eruption. ( 29104720 )
2017
14
Intertriginous and Seborrheic Dermatitis-Like Lesions in an Endocrine Patient. ( 29210714 )
2017
15
Prevalence and determinants of seborrheic dermatitis in a middle aged and elderly population: the Rotterdam Study. ( 28856679 )
2017
16
A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography. ( 28121079 )
2017
17
Cutaneous fungal microbiome: <i>Malassezia</i> yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial. ( 29484095 )
2017
18
The genetics of seborrheic dermatitis: a candidate gene approach and pilot genome-wide association study. ( 29203360 )
2017
19
Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. ( 27778328 )
2017
20
History of Seborrheic Dermatitis: Conceptual and Clinico-Pathologic Evolution. ( 28705278 )
2017
21
High Staphylococcus epidermidis Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis. ( 28685715 )
2017
22
Treatment of Seborrheic Dermatitis Using a Novel Herbal-based Cream. ( 28458770 )
2017
23
Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial. ( 28560305 )
2017
24
New perspectives on dandruff and seborrheic dermatitis: lessons we learned from bacterial and fungal skin microbiota. ( 28690211 )
2017
25
RF-Itraconazole Pulse Therapy for Seborrheic Dermatitis: A Treatment Approach to Consider. ( 28262107 )
2017
26
Low-Dose Isotretinoin for Seborrhoeic Dermatitis. ( 27777333 )
2017
27
Collapse of human scalp microbiome network in dandruff and seborrhoeic dermatitis. ( 28094891 )
2017
28
Seborrhoeic dermatitis. ( 28614013 )
2017
29
Histopathological Differential Diagnosis of Psoriasis and Seborrheic Dermatitis of the Scalp. ( 27489423 )
2016
30
Loss of MPZL3 Function Causes Seborrheic Dermatitis-like Phenotype in Mice. ( 27488654 )
2016
31
Seborrheic dermatitis treatment with stellate ganglion block: a case report. ( 27064785 )
2016
32
Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production. ( 26786542 )
2016
33
Diffuse HIV-associated seborrheic dermatitis - a case series. ( 27013615 )
2016
34
Comprehensive pyrosequencing analysis of the bacterial microbiota of the skin of patients with seborrheic dermatitis. ( 27301664 )
2016
35
Clinical manifestation and associated factors of seborrheic dermatitis in Korea. ( 26771150 )
2016
36
Noncorticosteroid Combination Shampoo versus 1% Ketoconazole Shampoo for the Management of Mild-to-Moderate Seborrheic Dermatitis of the Scalp: Results from a Randomized, Investigator-Single-Blind Trial Using Clinical and Trichoscopic Evaluation. ( 27171495 )
2016
37
Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial. ( 27648378 )
2016
38
Malassezia arunalokei sp. nov., a Novel Yeast Species Isolated from Seborrheic Dermatitis Patients and Healthy Individuals from India. ( 27147721 )
2016
39
Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study. ( 27904273 )
2016
40
Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis. ( 26868903 )
2016
41
Prevalence and related factors of psoriasis and seborrheic dermatitis: a community-based study. ( 27511489 )
2016
42
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. ( 27804089 )
2016
43
Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis. ( 28905039 )
2016
44
Anorectal melanoma and seborrheic dermatitis – A case report. ( 29648758 )
2016
45
Ketoconazole does not decrease fungal amount in patients with seborrhoeic dermatitis. ( 26920094 )
2016
46
Precipitation of free fatty acids generated by Malassezia - a possible explanation for the positive effects of lithium succinate in seborrhoeic dermatitis. ( 27072777 )
2016
47
Treatment of Seborrhoeic Dermatitis in Asia: A Consensus Guide. ( 27386464 )
2016
48
In vitro activity of kombucha tea ethyl acetate fraction against Malassezia species isolated from seborrhoeic dermatitis. ( 28959793 )
2016
49
Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair. ( 25657395 )
2015
50
Seborrheic Dermatitis and Dandruff: A Comprehensive Review. ( 27148560 )
2015
Sources

Variations for Seborrheic Dermatitis

About this section
Sources

Expression for Seborrheic Dermatitis

About this section
Search GEO for disease gene expression data for Seborrheic Dermatitis.
Sources

Pathways for Seborrheic Dermatitis

About this section
Sources

GO Terms for Seborrheic Dermatitis

About this section

Biological processes related to Seborrheic Dermatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of organ growth GO:0046621 8.62 CGA STK4
Sources

Sources for Seborrheic Dermatitis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....